Pharmareferent Cardiometabolic Health (m/w/d) Gebiet: Erlangen, Neustadt an der Aisch, Rothenburg ob der Tauber

Germany

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a scientific degree or certification as a certified pharmaceutical representative, with a minimum of two years of experience as a pharmaceutical representative. Proven expertise in diabetes care and experience within practices and clinics are essential. Strong sales skills, goal-oriented work habits, high social competence, excellent teamwork, and networking abilities are required. Proficiency in digital IT and modern communication channels for customer engagement, along with responsible, independent, and ethical conduct, are also necessary. Good English skills are a plus.

Responsibilities

The Pharmaceutical Representative will conduct sales discussions with specialists in practices, clinics, and pharmacies, utilizing digital communication channels. Responsibilities include implementing sales and marketing strategies, developing and executing regional action plans and contact route planning, organizing and conducting training events (including digital ones), and contributing to the design of events and workshops.

Skills

Cardiometabolic Health

Pharmaceutical Sales

Medical Device Sales

Customer Relationship Management

Territory Management

Sales

Marketing

Communication

Negotiation

Problem-Solving

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free